Fingerprint
Dive into the research topics of 'Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan
Takayuki Ikezoe, Kiyoshi Ando, Masahiro Onozawa, Takahisa Yamane, Naoko Hosono, Yasuyoshi Morita, Toru Kiguchi, Hiromi Iwasaki, Toshihiro Miyamoto, Keisuke Matsubara, Saori Sugimoto, Yasushi Miyazaki, Masahiro Kizaki, Koichi Akashi
Research output: Contribution to journal › Article › peer-review